Midi Health Valued at $1 Billion With $100 Million Round

<p><strong>PALO ALTO<&sol;strong> &&num;8212&semi; Midi Health&comma; a women’s telehealth company&comma; has raised &dollar;100 million in a Series D financing round led by Goodwater Capital with participation from new investors Foresite Capital and Serena Ventures&comma; as well as continued support from Advance Venture Partners&comma; GV &lpar;Google Ventures&rpar;&comma; Emerson Collective&comma; SemperVirens&comma; McKesson Ventures&comma; and Felicis Ventures&period; The round values the company at over &dollar;1 billion&comma; marking a pivotal moment for a long-ignored segment of healthcare&period;<&sol;p>&NewLine;<p>&OpenCurlyDoubleQuote;This is validation for the movement we’re leading to provide women better healthcare&comma;” said Joanna Strober&comma; co-founder and chief executive officer of Midi Health&period; &OpenCurlyDoubleQuote;Women’s health has been treated like an afterthought for too long&period; This funding gives us the resources to rewrite that story at scale&period;”<b><&sol;b><&sol;p>&NewLine;<p>Midi was founded to close the most persistent gaps in women’s care – gaps that carry enormous costs for women&comma; families&comma; and the economy&period; Two million U&period;S&period; women enter menopause each year&comma; and untreated symptoms alone cost an estimated &dollar;25 billion annually in medical expenses and lost productivity&period; Closing this gap – alongside many others women face across the lifespan – could add nearly &dollar;295 billion to the U&period;S&period; economy by 2040&period;<&sol;p>&NewLine;<p><b>AI in the Service of Women’s Healthcare<&sol;b><&sol;p>&NewLine;<p>Fueled by rapid patient adoption and notable outcomes&comma; the company has grown into a modern&comma; scalable health platform with nationwide insurance coverage now reaching more than 45 million women today&period; Each week&comma; more than 25&comma;000 patients turn to Midi for integrated care led by experts in OB-GYN&comma; internal medicine&comma; cardiology&comma; endocrine&comma; survivorship&comma; obesity&comma; sleep&comma; mood disorders&comma; dermatology&comma; longevity&comma; naturopathic medicine&comma; and more&period; By using AI to support clinical decision-making and reduce operational strain&comma; Midi is scaling its quality care experience to more women&period;<&sol;p>&NewLine;<p>Midi’s proprietary AI engine drives value in three main areas&colon;<&sol;p>&NewLine;<ul class&equals;"bwlistdisc">&NewLine;<li><b>Personalizing the experience&period; <&sol;b>AI-powered chart analysis tailors each patient’s care journey and supports faster&comma; more accurate diagnosis and care management&period;<&sol;li>&NewLine;<li><b>Streamlining operations&period;<&sol;b> Automation improves efficiency in scheduling&comma; triage&comma; and documentation&period;<&sol;li>&NewLine;<li><b>Improving outcomes&period;<&sol;b> Mining one of the industry’s largest women’s health datasets fuels research and refines clinical protocols&period;<&sol;li>&NewLine;<&sol;ul>&NewLine;<p>&OpenCurlyDoubleQuote;Goodwater is committed to Midi Health’s long-term mission to fundamentally transform women’s healthcare&comma;” said Eric Kim&comma; co-founder and managing partner at Goodwater Capital&period; &OpenCurlyDoubleQuote;Midi’s rise as the fastest-growing women’s health platform in the world is a testament to their entire care team&comma; patient-centric approach&comma; and AI advancements that deliver highly personalized care and scalable growth&period;”’<&sol;p>&NewLine;